Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-292519

Chief Executive Officer sold 8,220 shares at an average $39.83 ($327,398)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ceesay Abraham Chief Executive Officer 2026-06-29 Sale 10b5-1 −7,344 $39.77 $292,062 548,903 D
Ceesay Abraham Chief Executive Officer 2026-06-29 Sale 10b5-1 −876 $40.34 $35,336 548,027 D
Open-market sales · 8,220 sh · avg $39.83 · $327,398
Loading xslF345X06/ownership.xml…